Crispr Therapeutics shares owned by Perkins Coie Trust
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Perkins Coie Trust
from 13F filings
Historical chart of Perkins Coie Trust investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Perkins Coie Trust consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Perkins Coie Trust
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $6.8k | 200 | 34.02 |
| 2024-12-31 | $7.9k | 200 | 39.36 |
| 2024-09-30 | $9.4k | 200 | 46.97 |
| 2024-06-30 | $11k | 200 | 54.00 |
| 2024-03-31 | $14k | 200 | 68.15 |
| 2023-12-31 | $13k | 200 | 62.60 |